Xiongbin Lu

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 20

Top Venues

Nature communications

Oncogene

Nature biomedical engineering

Proceedings of the National Academy of Sciences of the United States of America

Indiana University School of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Indiana University School of Medicine Jun 15 2017

United States

Professor :: Medical and Molecular Genetics

Publications

Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, Tao Yu, Yujing Li, Zheng Ao, Sheng Liu, Lu Zhang, Yang Yang, Haniyeh Eyvani, Mary L Cox, Xiyu Wang, Xiaoming He, Guang Ji, Bryan P Schneider, Feng Guo, Jun Wan, Xinna Zhang, Xiongbin Lu
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nature biomedical engineering (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Zhuolong Zhou, Kevin Van der Jeught, Yujing Li, Samantha Sharma, Tao Yu, Ishara Moulana, Sheng Liu, Jun Wan, Paul R Territo, Mateusz Opyrchal, Xinna Zhang, Guohui Wan, Xiongbin Lu
A T Cell-Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Lei Han, Dayang Huang, Shiyong Wu, Sheng Liu, Cheng Wang, Yi Sheng, Xiongbin Lu, Hal E Broxmeyer, Jun Wan, Lei Yang
Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism. Nature cell biology (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Wenquan Ou, Samantha Stewart, Alisa White, Elyahb A Kwizera, Jiangsheng Xu, Yuanzhang Fang, James G Shamul, Changqing Xie, Suliat Nurudeen, Nikki P Tirada, Xiongbin Lu, Katherine H R Tkaczuk, Xiaoming He
In-situ cryo-immune engineering of tumor microenvironment with cold-responsive nanotechnology for cancer immunotherapy. Nature communications 14 (1) (2023)
Junyi Zhou, Xiaoyu Lu, Wennan Chang, Changlin Wan, Xiongbin Lu, Chi Zhang, Sha Cao
PLUS: Predicting cancer metastasis potential based on positive and unlabeled learning. PLoS computational biology 18 (3) (2022)
Juntae Kwon, Hyeongjwa Choi, Anna D Ware, Bernadette Cecilia Morillo, Haiyang Wang, Kerrie B Bouker, Xiongbin Lu, Todd Waldman, Cecil Han
USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model. Oncogene 41 (13) (2022)
Jianguang Du, Qun Wang, Shuangshuang Yang, Si Chen, Yongyao Fu, Sabine Spath, Phillip P Domeier, David Hagin, Stephanie Anover-Sombke, Maya Haouili, Sheng Liu, Jun Wan, Lei Han, Juli Liu, Lei Yang, Neel Sangani, Yujing Li, Xiongbin Lu, Sarath Chandra Janga, Mark H Kaplan, Troy R Torgerson, Gerald G Kellar, Baohua Zhou
FOXP3 exon 2 controls T reg stability and autoimmunity. Science immunology 7 (72) (2022)
Abhinav Achreja, Tao Yu, Anjali Mittal, Srinadh Choppara, Olamide Animasahun, Minal Nenwani, Fulei Wuchu, Noah Meurs, Aradhana Mohan, Jin Heon Jeon, Itisam Sarangi, Anusha Jayaraman, Sarah Owen, Reva Kulkarni, Michele L Dziubinski, Frank Weinberg, Hye Kyong Kweon, Chitra Subramanian, Max S Wicha, Sofia D Merajver, Sunitha Nagrath, Kathleen R Cho, Analisa DiFeo, Xiongbin Lu, Deepak Nagrath
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer. Nature metabolism 4 (9) (2022)
Chuanpeng Dong, Jill L Reiter, Edward Dong, Yue Wang, Kelvin P Lee, Xiongbin Lu, Yunlong Liu
Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer. JCO clinical cancer informatics 6 (2022)
Zheng Ao, Hongwei Cai, Zhuhao Wu, Liya Hu, Asael Nunez, Zhuolong Zhou, Hongcheng Liu, Maria Bondesson, Xiongbin Lu, Xin Lu, Ming Dao, Feng Guo
Microfluidics guided by deep learning for cancer immunotherapy screening. Proceedings of the National Academy of Sciences of the United States of America 119 (46) (2022)
Chuanpeng Dong, Annamaria Cesarano, Giuseppe Bombaci, Jill L Reiter, Christina Y Yu, Yue Wang, Zhaoyang Jiang, Mohammad Abu Zaid, Kun Huang, Xiongbin Lu, Brian A Walker, Fabiana Perna, Yunlong Liu
Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma. Oncogene 40 (42) (2021)
Yujing Li, Yifan Sun, Michael Kulke, Torsten Hechler, Kevin Van der Jeught, Tianhan Dong, Bin He, Kathy D Miller, Milan Radovich, Bryan P Schneider, Andreas Pahl, Xinna Zhang, Xiongbin Lu
Targeted immunotherapy for HER2-low breast cancer with 17p loss. Science translational medicine 13 (580) (2021)
Hai Wang, Yutong Liang, Yue Yin, Jie Zhang, Wen Su, Alisa M White, null Bin Jiang, Jiangsheng Xu, Yuntian Zhang, Samantha Stewart, Xiongbin Lu, Xiaoming He
Carbon nano-onion-mediated dual targeting of P-selectin and P-glycoprotein to overcome cancer drug resistance. Nature communications 12 (1) (2021)
Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, Tao Yu, Yujing Li, Zheng Ao, Sheng Liu, Lu Zhang, Yang Yang, Haniyeh Eyvani, Mary L Cox, Xiyu Wang, Xiaoming He, Guang Ji, Bryan P Schneider, Feng Guo, Jun Wan, Xinna Zhang, Xiongbin Lu
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nature biomedical engineering 5 (11) (2021)
Lei Sun, Arabella Wan, Zhuolong Zhou, Dongshi Chen, Heng Liang, Chuwei Liu, Shijia Yan, Yi Niu, Ziyou Lin, Siyue Zhan, Shanfeng Wang, Xianzhang Bu, Weiling He, Xiongbin Lu, Anlong Xu, Guohui Wan
RNA-binding protein RALY reprogrammes mitochondrial metabolism via mediating miRNA processing in colorectal cancer. Gut 70 (9) (2020)

Xiongbin Lu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiongbin Lu